Segment disclosures

Company overview

코썬바이오

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 9 retained observations 7 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-3185848038 KRW20200522Open filing evidence
2019-01-01 – 2019-12-312695515597 KRW20200331Open filing evidence
2019-07-01 – 2019-09-30-177579132 KRW20191114Open filing evidence
2019-01-01 – 2019-09-301509048161 KRW20191114Open filing evidence
2019-01-01 – 2019-03-31649587726 KRW20200522Open filing evidence
2018-01-01 – 2018-12-319538710566 KRW20200331Open filing evidence
2018-07-01 – 2018-09-30640384061 KRW20191114Open filing evidence
2018-01-01 – 2018-09-303149433358 KRW20191114Open filing evidence
2017-01-01 – 2017-12-3125656054901 KRW20200331Open filing evidence